Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CoronaVac + Inlive
- Development stage
- Phase 4
- Lead developer
- Sinovac Biotech
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
CoronaVac + Inlive is a vaccine combination regimen consisting of the simultaneous administration of two separate inactivated vaccines developed by Sinovac Biotech: CoronaVac (an inactivated SARS-CoV-2 vaccine) and Inlive (an inactivated Enterovirus 71 vaccine). CoronaVac is derived from the CZ02 strain of SARS-CoV-2, while Inlive is derived from the H07 strain (subgenotype C4) of Enterovirus 71. Both vaccines are produced using Vero cells and are formulated with aluminum hydroxide as an adjuvant. This co-administration approach was specifically evaluated in Phase IV clinical trials to determine the safety and immunogenicity of providing protection against both COVID-19 and Hand, Foot, and Mouth Disease (HFMD) in pediatric populations, specifically children aged 3 to 5 years.
- Other names
- COVID-19 vaccine (Vero cell), InactivatedEV71 vaccine (Vero cell), InactivatedEnterovirus Type 71 Vaccine (Inactivated, Vero Cell)
02
Targets
DPP-4 (Dipeptidyl Peptidase-IV)
Beyond the preview
Go deeper on CoronaVac + Inlive.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CoronaVac + Inlive.